Product
Semaglutide B
Aliases
Semaglutide B, 1.34 mg/mL
2 clinical trials
4 indications
Indication
Healthy VolunteersIndication
Type 2Indication
Diabetes MellitusIndication
Healthy ParticipantsClinical trial
A Study to Demonstrate Bioequivalence Between Semaglutide Formulation for the DV3396 Pen-injector and the Formulation for the PDS290 Semaglutide Pen-injectorStatus: Completed, Estimated PCD: 2022-08-30
Clinical trial
A Study to Demonstrate Bioequivalence Between Semaglutide Drug Product Concentrations 0.68 mg/mL and 1.34 mg/mLStatus: Completed, Estimated PCD: 2023-05-30